GeneReach Biotechnology Corp. (4171.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$16.70 (-1.76%) as of
Key statistics
- Market cap
- 949.52M
- EPS (TTM)
- -0.76
- Dividend yield
- 0.00%
- 52-week range
- 16.05 – 26.90
- Beta
- 0.37
- Revenue (TTM)
- 238.08M
- Profit margin
- -18.10%
- Volume
- 78.27k
About GeneReach Biotechnology Corp.
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ2000 Detection & Prevention System. It also provides training program; and other services comprising molecular diagnostic technical solutions and laboratory installation, OEM/ODM contract manufacturing, and research collaborations services. The company was founded in 2004 and is headquartered in Taichung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taichung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.